Table 2

Treatment regimen on the day of glucocorticoid discontinuation

Treatment regimenSLE without prior severe organ involvement (n=24)SLE with prior severe organ involvement (n=49)P value
GC dosage (mg/day)*0.00(0.00, 0.00)0.00(0.00, 0.00)N/A
HCQ10 (41.7)26 (53.1)0.46
Tac5 (20.8)20 (40.8)0.12
CyA0 (0.0)1 (2.0)1.0
MMF0 (0.0)6 (12.2)0.17
MZR3 (12.5)14 (28.6)0.15
AZA0 (0.0)2 (4.1)1.0
MTX3 (12.5)2 (4.1)0.32
SASP2 (8.3)0 (0.0)0.11
IGU0 (0.0)1 (2.0)1.0
BUC1 (4.2)0 (0.0)0.33
BEL/RTX/CY/PE/IVIg0 (0.0)0 (0.0)NA
  • Values are expressed as number (%) or median (IQR).

  • *Prednisolone equivalent (mg/day).

  • AZA, azathioprine; BEL, belimumab; BUC, bucillamine; CY, cyclophosphamide; CyA, ciclosporin; GC, glucocorticoid; HCQ, hydroxychloroquine; IGU, iguratimod; IVIg, intravenous immunoglobulin; MMF, mycophenolate mofetil; MTX, methotrexate; MZR, mizoribine; N/A, not applicable; PE, plasma exchange; RTX, rituximab; SASP, salazosulfapyridine; Tac, tacrolimus.